{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:45:14Z","timestamp":1764175514390,"version":"3.44.0"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.amjcard.2023.08.167","type":"journal-article","created":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T11:38:27Z","timestamp":1694864307000},"page":"493-494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Expanding the Indication for Selective Heart Rate Reduction: Chronic Obstructive Pulmonary Disease With Corpulmonale"],"prefix":"10.1016","volume":"207","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2685-4165","authenticated-orcid":false,"given":"Guy A.","family":"MacGowan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2023.08.167_bib0001","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/oxfordjournals.eurheartj.a015465","article-title":"The relationship between resting heart rate and all-cause, cardiovascular and cancer mortality","volume":"18","author":"Mensink","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2023.08.167_bib0002","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/0002-8703(87)90666-1","article-title":"Heart rate and cardiovascular mortality: the Framingham Study","volume":"113","author":"Kannel","year":"1987","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2023.08.167_bib0003","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.21037\/jtd-21-779","article-title":"Associations between sinus tachycardia and adverse cardiovascular outcomes and mortality in cancer patients","volume":"13","author":"Hemu","year":"2021","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.amjcard.2023.08.167_bib0004","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1161\/01.HYP.30.5.1267","article-title":"Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations","volume":"30","author":"Palatini","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.amjcard.2023.08.167_bib0005","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/joim.12333","article-title":"Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and Transcend studies","volume":"278","author":"B\u00f6hm","year":"2015","journal-title":"J Intern Med"},{"key":"10.1016\/j.amjcard.2023.08.167_bib0006","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0140-6736(10)61259-7","article-title":"Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial","volume":"376","author":"B\u00f6hm","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2023.08.167_bib0007","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2023.08.167_bib0008","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/01.CIR.86.1.12","article-title":"Pathogenesis of congestive state in chronic obstructive pulmonary disease. Studies of body water and sodium, renal function, hemodynamics, and plasma hormones during edema and after recovery","volume":"86","author":"Anand","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2023.08.167_bib0009","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1183\/09031936.00072212","article-title":"Resting heart rate is a predictor of mortality in COPD","volume":"42","author":"Jensen","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjcard.2023.08.167_bib0010","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ihj.2021.03.009","article-title":"Effect of ivabradine on heart rate, functional capacity and pulmonary artery pressure in patients of COPD with cor pulmonale","volume":"73","author":"Kaleem","year":"2021","journal-title":"Indian Heart J"},{"key":"10.1016\/j.amjcard.2023.08.167_bib0011","doi-asserted-by":"crossref","first-page":"419","DOI":"10.7861\/clinmedicine.16-5-419","article-title":"The effect of ivabradine on functional capacity in patients with chronic obstructive pulmonary disease","volume":"16","author":"Mahmoud","year":"2016","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.amjcard.2023.08.167_bib0012","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.amjcard.2023.08.094","article-title":"Effects of ivabradine on right ventricular systolic function in patients with chronic obstructive pulmonary disease and cor pulmonale","volume":"207","author":"Rossi","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2023.08.167_bib0013","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/j.jacc.2013.07.027","article-title":"Selective heart rate reduction with ivabradine unloads the left ventricle in heart failure patients","volume":"62","author":"Reil","year":"2013","journal-title":"J Am Coll Cardiol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914923009475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914923009475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:51:25Z","timestamp":1757573485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914923009475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":13,"alternative-id":["S0002914923009475"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.08.167","relation":{},"ISSN":["0002-9149"],"issn-type":[{"type":"print","value":"0002-9149"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expanding the Indication for Selective Heart Rate Reduction: Chronic Obstructive Pulmonary Disease With Corpulmonale","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.08.167","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.08.094","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}